Structural and Antibacterial Characterization of a New Benzamide FtsZ Inhibitor with Superior Bactericidal Activity and In Vivo Efficacy Against Multidrug-Resistant Staphylococcus aureus
ACS Chemical Biology · 17.03.2023 · 18 (3) · 629-642
DOI: 10.1021/acschembio.2c00934 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 28.02.2023. Verfasst von Eric Bryan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Rutgers Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, New Jersey 08854, United States. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Prodrugs, Staphylococcal Infections. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Osaka University, Takeda Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Rutgers Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, New Jersey 08854, United States.
- Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers University, 160 Frelinghuysen Road, Piscataway, New Jersey 08854, United States.
- TAXIS Pharmaceuticals, Inc., 9 Deer Park Drive, Suite J-15, Monmouth Junction, New Jersey 08852, United States.
- Department of Applied Chemistry, Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
- Department of Biotechnology, College of Life Sciences, Ritsumeikan University, 1-1-1 Noji-higashi, Shiga 525-8577, Japan.
ORCID-Profile: Edgar Ferrer-González, Junso Fujita, Hiroyoshi Matsumura, Daniel S Pilch
Förderung
- NIAID NIH HHS
- Osaka University
- Takeda Science Foundation
- National Institute of Allergy and Infectious Diseases
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan
Zitieren
APA
Bryan, E., Ferrer-González, E., Sagong, H. Y., Fujita, J., Mark, L., Kaul, M., LaVoie, E. J., Matsumura, H., & Pilch, D. S. (2023). Structural and Antibacterial Characterization of a New Benzamide FtsZ Inhibitor with Superior Bactericidal Activity and In Vivo Efficacy Against Multidrug-Resistant Staphylococcus aureus. ACS Chemical Biology, 18(3), 629-642. https://doi.org/10.1021/acschembio.2c00934
Vancouver
Bryan E, Ferrer-González E, Sagong HY, Fujita J, Mark L, Kaul M, et al. Structural and Antibacterial Characterization of a New Benzamide FtsZ Inhibitor with Superior Bactericidal Activity and In Vivo Efficacy Against Multidrug-Resistant Staphylococcus aureus. ACS Chemical Biology. 2023;18(3):629-642. doi:10.1021/acschembio.2c00934
BibTeX
@article{Bryan2023,
author = {Bryan, Eric and Ferrer-González, Edgar and Sagong, Hye Yeon and Fujita, Junso and Mark, Lilly and Kaul, Malvika and LaVoie, Edmond J and Matsumura, Hiroyoshi and Pilch, Daniel S},
title = {Structural and Antibacterial Characterization of a New Benzamide FtsZ Inhibitor with Superior Bactericidal Activity and In Vivo Efficacy Against Multidrug-Resistant Staphylococcus aureus},
journal = {ACS Chemical Biology},
year = {2023},
volume = {18},
number = {3},
pages = {629--642},
doi = {10.1021/acschembio.2c00934}
}
EUVIMED